Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06977438 · ClinicalTrials.gov registry record · Phase 4
GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward
A Phase 4 study, sponsored by University of Minnesota.
- Not yet
- Registry status
- Phase 4
- Development phase
- 1,020
- Enrollment target
NCT06977438 is a Phase 4 study that has not yet begun recruiting, run by University of Minnesota. The registered enrollment target is 1,020 participants.
The verdict
NCT06977438, a Phase 4 study, has not yet begun recruiting, sponsored by University of Minnesota.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 1,020 participants
- Enrollment target
Study Summary
The rapid emergence of new and highly effective obesity medications has turned the field of pediatric weight management on its head. Adolescents living with obesity, their caregivers, healthcare providers, healthcare systems, policymakers, and payors are now wondering what role health behavior and lifestyle treatment (HBLT) has in terms of body mass index (BMI) reduction, improvements in quality of life and cardiometabolic health, and mitigating nutritional concerns when medications are used. Is intensive HBLT needed or could low intensity HBLT be an equally effective alternative; and if so, for whom? Our proposed project will answer these important questions that arise daily in the clinical setting and will generate critical new insights to guide decision-making for teens with obesity and the stakeholders who care deeply about them.
Interventions
- DRUG Semaglutide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,020 participants |
| Start Date | 2026-10-01 |
| Est. Completion | 2032-01-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06977438
The ClinicalTrials.gov registry entry for NCT06977438 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 1,020 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Semaglutide is the first listed.
NCT06977438 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06977438 about?
NCT06977438 is a clinical study titled "GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward". The rapid emergence of new and highly effective obesity medications has turned the field of pediatric weight management on its head. Adolescents living with obesity, their caregivers, healthcare providers, healthcare systems, policymakers, and payors are now wondering what role health behavior and l...
What is the current status of trial NCT06977438?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 1,020 participants. The study started on 2026-10-01. Estimated completion is 2032-01-31.
What interventions are being tested in trial NCT06977438?
The interventions under investigation include: Semaglutide (DRUG).
Who is sponsoring clinical trial NCT06977438?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.